Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Vis · SciRah

Researcher profile · Semantic Scholar

D. Vis

Share profile

D. Vis — researcher profile on SciRah

h-index: 25
Works: 72
Citations: 6,933

Most-cited papers

A Landscape of Pharmacogenomic Interactions in Cancer
F. Iorio, T. Knijnenburg, D. Vis, G. Bignell +35 more
2016Cell1,910 citations Open access
Semantic Scholar
UvA-DARE ( Digital Academic Repository ) Assessment of PLSDA cross validation
J. Westerhuis, H. Hoefsloot, S. Smit, D. Vis +4 more
20081,074 citations
Semantic Scholar
Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients
S. Ooft, F. Weeber, K. Dijkstra, C. McLean +19 more
2019Science Translational Medicine711 citations Open access
Semantic Scholar
Effective drug combinations in breast, colon and pancreatic cancer cells
P. Jaaks, E. Coker, D. Vis, O. Edwards +24 more
2022Nature391 citations Open access
Semantic Scholar
Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial
N. van Dijk, Alberto Gil-Jimenez, K. Silina, K. Hendricksen +20 more
2020Nature Medicine359 citations Open access
Semantic Scholar
Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality.
E. Gogola, A. Duarte, J. D. de Ruiter, W. Wiegant +23 more
2018Cancer Cell315 citations Open access
Semantic Scholar
Subunit composition of VRAC channels determines substrate specificity and cellular resistance to Pt-based anti-cancer drugs
R. Planells-Cases, Darius Lutter, C. Guyader, Nora M. Gerhards +14 more
2015EMBO Journal253 citations Open access
Semantic Scholar
UvA-DARE (Digital Academic Repository) T-profiler: scoring the activity of predefined groups of genes using gene expression data.
A. Boorsma, Barrett C. Foat, D. Vis, F. Klis +1 more
2005209 citations
Semantic Scholar
Genome-wide analysis of yeast stress survival and tolerance acquisition to analyze the central trade-off between growth rate and cellular robustness
A. Zakrzewska, Gerco van Eikenhorst, Johanna E. C. Burggraaff, D. Vis +5 more
2011Molecular Biology of the Cell176 citations Open access
Semantic Scholar
Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer
M. Michaut, Suet-Feung Chin, I. Majewski, T. Severson +42 more
2016Scientific Reports165 citations Open access
Semantic Scholar
Statistical validation of megavariate effects in ASCA
D. Vis, J. Westerhuis, A. Smilde, J. van der Greef
2007BMC Bioinformatics154 citations Open access
Semantic Scholar
Intra- and inter-tumor heterogeneity in a vemurafenib-resistant melanoma patient and derived xenografts
K. Kemper, O. Krijgsman, P. Cornelissen-Steijger, A. Shahrabi +11 more
2015EMBO Molecular Medicine129 citations Open access
Semantic Scholar
MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer models
Z. Xue, D. Vis, A. Bruna, Tonći Šuštić +7 more
2018Cell Research106 citations Open access
Semantic Scholar
Phenotyping tea consumers by nutrikinetic analysis of polyphenolic end-metabolites.
E. V. van Velzen, J. Westerhuis, J. V. van Duynhoven, F. V. van Dorsten +5 more
2009Journal of Proteome Research99 citations
Semantic Scholar
Facilitating a Culture of Responsible and Effective Sharing of Cancer Genome Data
L. Siu, M. Lawler, D. Haussler, B. Knoppers +19 more
2016Nature Medicine89 citations Open access
Semantic Scholar
Multilevel models improve precision and speed of IC50 estimates
D. Vis, L. Bombardelli, H. Lightfoot, F. Iorio +2 more
2016Pharmacogenomics (London)74 citations Open access
Semantic Scholar
TANDEM: a two-stage approach to maximize interpretability of drug response models based on multiple molecular data types
N. Aben, D. Vis, M. Michaut, L. Wessels
2016Bioinform.72 citations Open access
Semantic Scholar
Identification of a Druggable Pathway Controlling Glioblastoma Invasiveness.
N. Pencheva, M. D. de Gooijer, D. Vis, L. Wessels +3 more
2017Cell Reports67 citations Open access
Semantic Scholar
Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas
H. Reis, K. E. van der Vos, C. Niedworok, T. Herold +33 more
2018International Journal of Cancer59 citations Open access
Semantic Scholar
The Tumor Immune Landscape and Architecture of Tertiary Lymphoid Structures in Urothelial Cancer
N. van Dijk, Alberto Gil-Jimenez, K. Silina, M. V. van Montfoort +13 more
2021Frontiers in Immunology47 citations Open access
Semantic Scholar
Predicting patient response with models trained on cell lines and patient-derived xenografts by nonlinear transfer learning
Soufiane M. C. Mourragui, M. Loog, D. Vis, K. Moore +4 more
2021Proceedings of the National Academy of Sciences of the United States of America46 citations Open access
Semantic Scholar
Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer.
Alberto Gil-Jimenez, Jeroen van Dorp, A. Contreras-Sanz, K. E. van der Vos +15 more
2022European Urology45 citations Open access
Semantic Scholar
Evaluation of the HER/PI3K/AKT Family Signaling Network as a Predictive Biomarker of Pathologic Complete Response for Patients With Breast Cancer Treated With Neratinib in the I-SPY 2 TRIAL.
J. Wulfkuhle, C. Yau, D. Wolf, D. Vis +15 more
2018JCO Precision Oncology44 citations Open access
Semantic Scholar
Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality.
E. Gogola, A. Duarte, J. D. de Ruiter, W. Wiegant +23 more
2019Cancer Cell36 citations Open access
Semantic Scholar
TLE3 loss confers AR inhibitor resistance by facilitating GR-mediated human prostate cancer cell growth
S. Palit, D. Vis, S. Stelloo, C. Lieftink +11 more
2019eLife32 citations Open access
Semantic Scholar
Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors
Alberto Gil-Jimenez, N. van Dijk, J. Vos, Yoni Lubeck +9 more
2023bioRxiv24 citations Open access
Semantic Scholar
Analyzing metabolomics-based challenge tests
D. Vis, J. Westerhuis, D. Jacobs, J. V. van Duynhoven +4 more
2015Metabolomics24 citations Open access
Semantic Scholar
NASP modulates histone turnover to drive PARP inhibitor resistance
S. Moser, Anna Khalizieva, Josef Roehsner, Elisabeth Pottendorfer +25 more
2025Nature22 citations Open access
Semantic Scholar
Towards a global cancer knowledge network: dissecting the current international cancer genomic sequencing landscape
D. Vis, J. Lewin, R. Liao, M. Mao +11 more
2017Annals of Oncology22 citations Open access
Semantic Scholar
Ovarian Cancer–Specific BRCA-like Copy-Number Aberration Classifiers Detect Mutations Associated with Homologous Recombination Deficiency in the AGO-TR1 Trial
P. Schouten, L. Richters, D. Vis, S. Kommoss +22 more
2021Clinical Cancer Research19 citations Open access
Semantic Scholar
A kinome-centered CRISPR-Cas9 screen identifies activated BRAF to modulate enzalutamide resistance with potential therapeutic implications in BRAF-mutated prostate cancer
S. Palit, Jeroen van Dorp, D. Vis, C. Lieftink +5 more
2021Scientific Reports18 citations Open access
Semantic Scholar
Endocrine pulse identification using penalized methods and a minimum set of assumptions.
D. Vis, J. Westerhuis, H. Hoefsloot, H. Pijl +3 more
2010American Journal of Physiology. Endocrinology and Metabolism18 citations
Semantic Scholar
Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancer
Xiao-Lin Zhu, Tatyanah Farsh, D. Vis, I. Yu +20 more
2024Journal of Clinical Investigation16 citations Open access
Semantic Scholar
T-profiler: scoring the activity of predefined groups of genes using gene expression data
A. Boorsma, Barrett C. Foat, D. Vis, F. Klis +1 more
2005Nucleic Acids Res.14 citations Open access
Semantic Scholar
Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer
K. E. van der Vos, D. Vis, E. Nevedomskaya, Y. Kim +6 more
2020Scientific Reports13 citations Open access
Semantic Scholar
Genomic data integration by WON-PARAFAC identifies interpretable factors for predicting drug-sensitivity in vivo
Yongsoo Kim, T. Bismeijer, W. Zwart, L. Wessels +1 more
2019Nature Communications13 citations Open access
Semantic Scholar
Detecting Regulatory Mechanisms in Endocrine Time Series Measurements
D. Vis, J. Westerhuis, H. Hoefsloot, F. Roelfsema +2 more
2012PLoS ONE10 citations Open access
Semantic Scholar
Multiset data analysis: ANOVA simultaneous component analysis and related methods
H. Hoefsloot, D. Vis, J. Westerhuis, A. Smilde +4 more
200910 citations
Semantic Scholar
A pan-cancer screen identifies drug combination benefit in cancer cell lines at the individual and population level
D. Vis, P. Jaaks, N. Aben, E. Coker +11 more
2024Cell Reports Medicine8 citations Open access
Semantic Scholar
Platinum-based chemotherapy induces opposing effects on immunotherapy response-related spatial and stromal biomarkers in the bladder cancer microenvironment.
M. Chelushkin, Jeroen van Dorp, S. van Wilpe, I. M. Seignette +16 more
2024Clinical Cancer Research7 citations Open access
Semantic Scholar
Predicting clinical drug response from model systems by non-linear subspace-based transfer learning
Soufiane M. C. Mourragui, M. Loog, D. Vis, K. Moore +4 more
2020bioRxiv7 citations Open access
Semantic Scholar
Correlated measurement error hampers association network inference.
M. Kaduk, H. Hoefsloot, D. Vis, T. Reijmers +3 more
2014Journal of chromatography. B, Analytical technologies in the biomedical and life sciences7 citations
Semantic Scholar
Biomarker analysis and updated clinical follow-up of preoperative ipilimumab (ipi) plus nivolumab (nivo) in stage III urothelial cancer (NABUCCO).
N. van Dijk, Alberto Gil-Jimenez, K. Silina, K. Hendricksen +16 more
2020Journal of Clinical Oncology6 citations
Semantic Scholar
Abstract A44: A landscape of pharmacogenomic interactions in cancer
F. Iorio, T. Knijnenburg, D. Vis, G. Bignell +5 more
20176 citations
Semantic Scholar
Second‐line Chemotherapy in Older Patients With Metastatic Urothelial Carcinoma: Pooled Analysis of 10 Second‐line Studies
S. Salah, Jae-Lyun Lee, A. Rozzi, H. Kitamura +10 more
2017Clinical Genitourinary Cancer5 citations
Semantic Scholar
Determining barriers to effective data sharing in cancer genomic sequencing initiatives: A Global Alliance for Genomics and Health (GA4GH) survey.
J. Lewin, D. Vis, E. Voest, R. Liao +16 more
20165 citations
Semantic Scholar
Identifying biomarkers of anti-cancer drug synergy using multi-task learning
N. Aben, J. D. de Ruiter, Evert Bosdriesz, Yongsoo Kim +4 more
2018bioRxiv2 citations Open access
Semantic Scholar
Abstract 5287: Heterogeneity of mutation calling and annotation: a survey of cancer next-generation sequencing initiatives by the Global Alliance for Genomics and Health (GA4GH):
D. Vis, J. Lewin, L. Siu, R. Liao +16 more
20162 citations
Semantic Scholar
A technical note on challenge tests in human volunteers for multidimensional phenotyping
D. Vis, M. Hendriks, M. Sailer, A. Smilde +2 more
20142 citations
Semantic Scholar
Somatostatin receptor 1 (SSTR1) expression as a potential predictive biomarker for response to androgen receptor signaling inhibitor (ARSI) therapy in metastatic castration-resistant prostate cancer (mCRPC).
Xiao-Lin Zhu, D. Vis, Martin Sjöström, Raunak Shrestha +16 more
2024Journal of Clinical Oncology1 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Wessels×21
Invite
L. Wessels — researcher profile on SciRah
M. S. van der Heijden×12
Invite
M. S. van der Heijden — researcher profile on SciRah
A. Smilde×9
Invite
A. Smilde — researcher profile on SciRah
J. Westerhuis×8
Invite
J. Westerhuis — researcher profile on SciRah

B. V. van Rhijn

×8

Invite

B. V. van Rhijn — researcher profile on SciRah

H. Hoefsloot×6

Invite

H. Hoefsloot — researcher profile on SciRah

Alberto Gil-Jimenez×6

Invite

Alberto Gil-Jimenez — researcher profile on SciRah

Invite

L. Wessels — researcher profile on SciRah

Invite

N. Aben — researcher profile on SciRah

Invite

M. Garnett — researcher profile on SciRah

Invite

E. Voest — researcher profile on SciRah

M. V. van Montfoort×5

Invite

M. V. van Montfoort — researcher profile on SciRah